Daily Brief Archive: July 14, 2026 — U.S. & Hong Kong Stock Analysis
Free previewU.S. Markets
- SK Hynix cratered 15.4% — its worst day ever — dragging the SOX down; SOXL fell 14% in one session
- KOSPI plunged 9.95%, tripping its 7th circuit breaker this year; Samsung -10.7%, index now 27% off the June peak
- US-Iran strikes escalated: Tehran declared Hormuz 'unnavigable'; Brent jumped 5% through $80
- Energy bucked the tape: XLE +3%, XOP +4.2%; richly valued software dumped — AppLovin's 5-day slide hit -18.6%
- Oracle fell 6.5% for a ninth straight loss and a fresh 52-week low — no antidote yet for the capex-and-debt narrative
- Microsoft +1.5% and IBM +0.9%: defensive money hid in big-cap value tech
Hong Kong
- Hang Seng opened soft this morning; tech lagged — Baidu fell as much as 8% to lead decliners, Zhipu -10%
- Kunlunxin's IPO 'bundling' clause stirred controversy; the market voted with its feet on Baidu's spin-off premium
- Oil & petrochemicals outperformed: Sinopec +2.4%; Zijin +3.3% as gold-copper repair continued
- CXO names hit highs against the tape: Asymchem +4.9% near a record, WuXi Bio printed another swing high
- GigaDevice V-bounced 9.5% the day after its lock-up expiry; MiniMax caught a 3.3% oversold breather
- Lithium bounced from oversold: Ganfeng +2.8%, Tianqi +3.3% — the weekly wounds are far from healed
Today's Watchlist
- Tonight 8:30pm HKT: US June CPI — consensus sees 4.2%→3.9%, core 2.9%; the year's biggest data point
- All five megabanks report premarket tonight; the SpaceX IPO lifts group IB revenue estimates by 26%
- New Fed Chair Warsh gives his first Congressional testimony; markets are pricing rising odds of a September hike
- Hormuz: US floats a maritime blockade plus a 20% transit levy — oil risks a second spike
- Position tripwires: TSLA $390, NVDA $196, BEAM $30.5, CELH $29.6
- Ahead: TSLA and IBM report 7/22; SpaceX's first earnings and first lock-up expiry land 8/6
Deep Dives (0 names)
No deep-dive names match the current filters
Rapid Scan (5 names)
| Ticker | Close | Change | Score | Direction | One-line take |
|---|---|---|---|---|---|
| $21.38 | +90.72% | 5 | Neutral | Up 90.7% to $21.38 on 41x volume — a biotech microcap doubling in a day is a lottery draw, not a signal; winners cash out, everyone else skip the makeup ticket | |
| $6.43 | +16.59% | 4 | Neutral | Up 16.6% to $6.43 on 107x volume — a meme-stock soap opera; watch, don't audition | |
| $40.17 | -9.16% | 4 | Neutral | Down 9.2% to $40.17 on 26x volume — heavy selling in a news vacuum is a walk-away; sidelines | |
| $60.07 | +11.99% | 5 | Neutral | Up 12.0% to $60.07 on 13x volume — regional-bank action smells like M&A theater; don't guess the script | |
| $42.41 | +10.21% | 5 | Neutral | Up 10.2% to $42.41 on 3.4x volume — the medtech smallcap popped, but consensus targets sit below; sidelines |